Fragrance Giants Face Fresh Antitrust Probe in India Over Price-Fixing Allegations
NEW DELHI – Three of the world’s largest fragrance manufacturers are under renewed scrutiny from Indian regulators, marking a significant escalation in the legal challenges facing the industry. According to confidential regulatory documents reviewed by Reuters, Givaudan, Firmenich, and International Flavors & Fragrances (IFF) are being investigated for alleged price collusion within the Indian market.
This latest inquiry, initiated by the Competition Commission of India (CCI), represents a secondary layer of legal pressure for the firms, which are already embroiled in an ongoing investigation regarding potential “no-poach” agreements—allegations that the companies colluded to suppress labor competition by agreeing not to hire each other’s employees.
A Growing Regulatory Cloud
The July 22 document from the CCI identifies the new case as an inquiry into “alleged cartelisation” within the Indian fragrance industry dating back to 2024. These companies are no strangers to such scrutiny; they have faced similar accusations regarding pricing strategies in various international markets, including ongoing investigations by authorities in Switzerland and the United Kingdom. While the European Commission has similarly announced probes into potential collusion involving fragrance supplies and ingredients, it has yet to formally name the targets of its investigation.
The Indian market is a critical growth area for these firms. According to data from Grand View Research, the nation’s flavors and fragrances sector is projected to double in value, reaching $5 billion by 2033, up from $2.5 billion in 2024.
Procedural Hurdles and Data Security
The investigation has hit a procedural snag that threatens to delay the resolution of the two-year-old case. In February, the CCI had initially prepared a report outlining its findings, which was subsequently shared with the companies. However, in July, the watchdog was forced to recall the report following formal complaints from Givaudan and IFF. The companies argued that the document contained unredacted commercial secrets that could be damaging if disclosed.
The CCI must now redraft the report to ensure all sensitive proprietary information is protected. Antitrust experts suggest this is a notable setback for the regulator.
“From a systemic perspective, this will be of concern to CCI,” said Gautam Shahi, an antitrust lawyer at Dua Associates. “Loss of relevant commercially sensitive data may harm competition in the market.”
Industry Silence
The companies involved—Swiss-based Givaudan, the U.S.-based IFF, and DSM-Firmenich (formed by the 2023 merger of Dutch specialty chemicals giant DSM and Firmenich)—have largely remained silent regarding the specific allegations in India. When approached for comment, none of the firms responded, nor did the Competition Commission of India.
In previous statements regarding global anti-cartel probes, the companies have maintained that they are cooperating fully with regulatory authorities. As the price collusion investigation continues, the fragrance industry remains in a precarious position, facing both a tightening regulatory environment and the logistical challenges of protecting trade secrets during transparency-driven legal proceedings.
